Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Toripalimab Combined With Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma: A Multicenter Prospective, Single-arm, Phase II Clinical Trial

NCT06415318 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT06415318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06415318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Toripalimab Combined With Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma: A Multicenter Prospective, Single-arm, Phase II Clinical Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2024
Completion date
August 30, 2026
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

penile cancer